Searched for
PHARMACEUTICAL REVENUE
Indian SME pharma firms see shift of orders from China; cost, quality concerns remainSmall and mid-sized Indian pharmaceutical firms are witnessing a shift in orders away from China. As Western buyers diversify their supply ...
ETSA 2026: Consumer brands poised for bigger exits as strategic acquisitions pick up: Sauce’s Manu ChandraChandra has been selected for the Midas Touch honour for best investor at The ET Startup Awards 2026, with the jury recognising his track r...
5 stocks with consistent score improvement and upside potential of up to 32% in 1 year, according to analystsFor the next few weeks, the markets will readjust as business updates, which have started to arrive, and the Q2 earnings numbers roll in. C...
Inox Air Products files IPO papers; issue size not disclosedInox Air Products has unveiled a draft red herring prospectus as it seeks to raise substantial funds through an initial public offering. As...
AI productivity gains reflecting in salaries would take another 12 months: Wipro’s Jasjit KangWipro’s Jasjit Kang says broad productivity improvements remain elusive as the company looks for stronger AI, problem-solving and learning ...
In 1944, a retired IRS auditor Anne Scheiber invested $5,000 in stocks; 51 years later, her portfolio was worth $22 millionAnne Scheiber reportedly retired in the mid-1940s with an annual salary of about $3,150. She had never been promoted. Her pay had also chan...
ChrysCapital to take minority stake in Linux laboratoriesLinux Laboratories has secured $70 million in equity funding from ChrysCapital and Tata Capital Healthcare Fund III. This investment involv...
Anupam Rasayan completes Bliss GVS deal, targets Rs 4,000-crore integrated platformAnupam Rasayan India Limited has finalised its acquisition of a controlling interest in Bliss GVS Pharma, marking a strategic expansion int...
Steamhouse India wins Rs 311 crore EPC mandate for 300 TPH steam project in Himachal PradeshSteamhouse India Ltd has secured a Rs 311 crore EPC mandate for a 300 TPH common steam and co-generation power plant at the Bulk Drug Park ...
Rs 78,400 vs Rs 7,750 medicine: Novartis, Eli Lilly oppose bid to cut breast cancer drug prices in IndiaNovartis and Eli Lilly have opposed a Kerala High Court petition seeking government intervention to make two breast cancer drugs cheaper, d...
Deon Energy files draft papers with Sebi to raise funds via IPODeon Energy, an Ahmedabad-based solar EPC firm, is set to launch an IPO to gather capital. This offering will feature a fresh equity share ...
Govt disburses Rs 36,754 cr under PLI schemes as on June 30The government has disbursed Rs 36,754 crore to beneficiary companies under the Production Linked Incentive schemes. These schemes have led...
NSE shares fall 2%, trade marginally above IPO price after debut. Why are Macquarie, other brokerages bullish?NSE shares fell by 1.6% to Rs 1,790 following its stock market debut on Thursday. Brokerages Macquarie and Emkay assigned positive ratings,...
Jagsonpal Pharma to acquire Group Pharma’s wellness portfolioJagsonpal Pharmaceuticals has signed a business transfer agreement to acquire the wellness portfolio of Group Pharmaceuticals. The acquisit...
Pharma sector revenue to grow 11-13 pc in FY27 on strong exports, domestic demand: CrisilIndia's pharmaceutical sector is projected to grow at 11-13 percent this fiscal year due to export increases. The domestic market is also e...
NSE draws brokerage attention on stock market debut as 3 firms initiate coverage on Day 1NSE shares rallied after a muted listing at Rs 1,800, pushing the exchange into India’s ninth-most valued company with a market cap of Rs 4...
MF Tracker: HDFC Pharma & Healthcare Fund tops equity MFs at 25% in 1 year. Should investors chase the rally?HDFC Pharma and Healthcare Fund recorded an impressive 25% return in the last year, surpassing its category average across various time fra...